Zurich Cantonal Bank
FULC icon

Zurich Cantonal Bank’s Fulcrum Therapeutics FULC Stock Holding History

Zurich Cantonal Bank’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.07K Buy
+1,182
New +$11K ﹤0.01% 2484
2025
Q1 		– Sell
-3
Closed -$14 – 2644
2024
Q4 		$14 Sell
3
-2,472
-100% -$9.12K ﹤0.01% 2643
2024
Q3 		$8.84K Hold
2,475
– – ﹤0.01% 2620
2024
Q2 		$15.3K Sell
2,475
-7
-0.3% -$53 ﹤0.01% 2601
2024
Q1 		$23.4K Buy
2,482
+459
+23% +$4.1K ﹤0.01% 2618
2023
Q4 		$13.7K Hold
2,023
– – ﹤0.01% 2670
2023
Q3 		$8.98K Sell
2,023
-668
-25% -$2.92K ﹤0.01% 2743
2023
Q2 		$8.88K Sell
2,691
-7,758
-74% -$22.8K ﹤0.01% 2750
2023
Q1 		$29.8K Buy
10,449
+7,794
+294% +$69.8K ﹤0.01% 2702
2022
Q4 		$19.3K Hold
2,655
– – ﹤0.01% 2759
2022
Q3 		$21K Hold
2,655
– – ﹤0.01% 2789
2022
Q2 		$13K Hold
2,655
– – ﹤0.01% 2835
2022
Q1 		$63K Hold
2,655
– – ﹤0.01% 2459
2021
Q4 		$47K Buy
+2,655
New +$52.6K ﹤0.01% 2759

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Zurich Cantonal Bank's FULC Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 1,182 shares worth $9.07K. The stake represents ﹤0.01% of the portfolio and ranks #2484 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in FULC as recently as Q4 2024.

Zurich Cantonal Bank first reported a position in FULC in Q4 2021 and has held it in 14 quarters since. The position peaked at $63K in Q1 2022. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Zurich Cantonal Bank held 1,182 shares of Fulcrum Therapeutics worth $9.07K as of Q1 2026.
  • Fulcrum Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2484 holding.
  • Zurich Cantonal Bank first reported a position in Fulcrum Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Zurich Cantonal Bank's Fulcrum Therapeutics position peaked at $63K in Q1 2022.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.